FY2024 EPS Estimates for KORU Medical Systems, Inc. Decreased by Analyst (NASDAQ:KRMD)

KORU Medical Systems, Inc. (NASDAQ:KRMD) – Research analysts at B. Riley lowered their FY2024 EPS estimates for shares of KORU Medical Systems in a report released on Wednesday, May 1st. B. Riley analyst W. Wood now expects that the company will post earnings of ($0.16) per share for the year, down from their prior forecast of ($0.15). B. Riley has a “Buy” rating and a $4.00 price objective on the stock. The consensus estimate for KORU Medical Systems’ current full-year earnings is ($0.16) per share.

KORU Medical Systems (NASDAQ:KRMD) last posted its quarterly earnings data on Wednesday, May 1st. The company reported ($0.02) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.02. The firm had revenue of $8.20 million for the quarter, compared to the consensus estimate of $7.49 million. KORU Medical Systems had a negative net margin of 45.24% and a negative return on equity of 25.10%. During the same period in the previous year, the firm earned ($0.05) EPS.

KORU Medical Systems Price Performance

KRMD opened at $2.32 on Monday. The company has a debt-to-equity ratio of 0.02, a current ratio of 4.01 and a quick ratio of 3.77. The company has a market capitalization of $106.16 million, a price-to-earnings ratio of -8.29 and a beta of 0.55. The firm’s fifty day moving average price is $2.20 and its two-hundred day moving average price is $2.23. KORU Medical Systems has a 1 year low of $1.98 and a 1 year high of $4.30.

Hedge Funds Weigh In On KORU Medical Systems

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Bard Associates Inc. boosted its holdings in shares of KORU Medical Systems by 22.5% in the 4th quarter. Bard Associates Inc. now owns 26,710 shares of the company’s stock worth $66,000 after buying an additional 4,910 shares during the last quarter. Mesirow Financial Investment Management Inc. purchased a new position in shares of KORU Medical Systems in the 1st quarter worth about $26,000. B. Riley Asset Management LLC boosted its holdings in shares of KORU Medical Systems by 2.7% in the 3rd quarter. B. Riley Asset Management LLC now owns 833,663 shares of the company’s stock worth $2,251,000 after buying an additional 21,738 shares during the last quarter. Eagle Asset Management Inc. boosted its holdings in shares of KORU Medical Systems by 70.1% in the 3rd quarter. Eagle Asset Management Inc. now owns 54,096 shares of the company’s stock worth $146,000 after buying an additional 22,299 shares during the last quarter. Finally, Advisor Resource Council purchased a new position in shares of KORU Medical Systems in the 1st quarter worth about $63,000. 58.60% of the stock is owned by hedge funds and other institutional investors.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.